Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Condition:   Osteoporosis and Cardio-Metabolic Syndrome Following Spinal Cord Injury Interventions:   Drug: Rosuvastatin Calcium;   Drug: Placebo Oral Tablet;   Dietary Supplement: Coenzyme Q10;   Dietary Supplement: Calcium Carbonate;   Dietary Supplement: Vitamin D Sponsors:   Dr. B. Catharine. Craven;   The Craig H. Neilsen Foundation;   Toronto Rehabilitation Institute;   University Health Network, Toronto;   University of Miami Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials